PS1418 POMALIDOMIDE‐BASED TREATMENT IN RELAPSED REFRACTORY MULTIPLE MYELOMA: ANALYSIS OF BASELINE CHARACTERISTICS AND SAFETY PROFILE OF PATIENTS WHO DIED IN THE EUROPEAN POST APPRO... von Gamberi, B., Abildgaard, N., Payer, A. Ramirez, Kyriakou, C., Hieber, M. Schmidt, Di Raimondo, F., Kueenburg, E., Di Micco, A., Rosettani, B., Atiba‐Davies, M., Bacon, P., Plesner, T.

Volltext

PB2117 POMALIDOMIDE PLUS LOW‐DEXAMETHASONE TREATMENT FOR ≥ 1 YEAR IN PATIENTS WITH RELAPSED REFRACTORY MULTIPLE MYELOMA AND RENAL IMPAIRMENT: A SUBANALYSIS OF THE MM‐013 PHASE 2 ST... von Weisel, K., Dimopoulos, M., Cook, M., Ramasamy, K., La Rubia, J., Ardizzoia, A., Krauth, M. T., Jaccard, A., Van de Donk, N., Kueenburg, E., Di Micco, A., Rosettani, B., Atiba‐Davies, M., Bacon, P., Sonneveld, P.

Volltext